6:34 PM
 | 
Oct 31, 2012
 |  BC Extra  |  Company News

GE Capital to invest in Biocon's Syngene

Biocon Ltd. (NSE:BIOCON; BSE:BIOCON) said General Electric Co. (NYSE:GE) will invest Rs1.2 billion ($22.8 million) to acquire a 7.69% stake in Biocon's research services subsidiary Syngene International Ltd. Biocon said the investment is part of its plan to take the CRO public "at...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >